Periviable birth at 20 to 26 weeks of gestation: proximate causes, previous obstetric history and recurrence risk

Brian Mercer1, Cynthia Milluzzi, Marc Collin

  • 1Department of Reproductive Biology, MetroHealth Medical Center at Case Western Reserve University, Cleveland, OH, USA.

Insights

Periviable birth, occurring between 20-26 weeks, is a high-risk event. While a previous periviable birth increases recurrence risk, it is not a reliable predictor for future pregnancies.

Area of Science:

  • Perinatal Medicine
  • Maternal-Fetal Medicine
  • Obstetrics

Background:

  • Periviable birth (20-26 weeks gestation) presents significant risks for infant mortality and morbidity.
  • Preventing periviable birth is crucial for improving infant outcomes.

Purpose of the Study:

  • To identify the causes of periviable birth.
  • To determine if previous pregnancy outcomes can predict subsequent periviable births.

Main Methods:

  • Analysis of 104,921 pregnancies from 1974-2004.
  • Assessment of periviable birth frequency, causes, and recurrence.
  • Evaluation of predictive values of first pregnancy outcomes for second pregnancy outcomes.

Main Results:

  • Periviable birth occurred in 1.9% of deliveries.
  • Common causes included labor (36%), premature rupture of membranes (34%), and bleeding (10%).
  • A prior periviable birth in the first pregnancy significantly increased the risk of periviable birth (RR 8.6) and preterm birth (RR 3.3) in the second pregnancy, but these were insensitive markers.

Conclusions:

  • While periviable birth recurrence is associated with previous periviable or preterm birth, these are not sensitive predictors.
  • There is a critical need for early pregnancy or preconceptional markers to predict periviable birth.
Abstract

Related Concept Videos

Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Varicose Veins I: Introduction01:26

Varicose Veins I: Introduction

Varicose veins, or varicosities, are abnormally dilated and twisted superficial veins caused by venous valve incompetence. This condition commonly affects the lower extremities, especially the saphenous veins, due to the higher pressure from prolonged standing and walking. However, varicosities can also occur in other areas, such as the esophagus, vulva, spermatic cords, and anorectal region.Etiology and typesPrimary varicose veins, often idiopathic, are more common in women due to inherent...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...